TNF Pharmaceuticals Files Q1 2025 10-Q
Ticker: QCLS · Form: 10-Q · Filed: May 15, 2025 · CIK: 1321834
| Field | Detail |
|---|---|
| Company | Tnf Pharmaceuticals, Inc. (QCLS) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, company-name-change
TL;DR
TNF Pharma (fka MyMD) filed its Q1 2025 10-Q. Check financials.
AI Summary
TNF Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as MyMD Pharmaceuticals, Inc., is involved in the in vitro & in vivo diagnostic substances industry. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with an update on TNF Pharmaceuticals' financial health and operational status for the first quarter of 2025, including any changes in its business or financial condition.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial and operational information that could reveal risks or opportunities for investors.
Key Players & Entities
- TNF Pharmaceuticals, Inc. (company) — Filer
- MyMD Pharmaceuticals, Inc. (company) — Former company name
- Akers Biosciences, Inc. (company) — Former company name
- 20250331 (date) — Period of report
- 20250515 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is 20250331, indicating the first quarter of 2025.
What was TNF Pharmaceuticals, Inc. formerly known as?
TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc., and prior to that, Akers Biosciences, Inc.
What is the primary industry of TNF Pharmaceuticals, Inc.?
The company's Standard Industrial Classification is IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835].
Where is TNF Pharmaceuticals, Inc. located?
The company's business and mail address is 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY 10036.
When was the company's name changed from MyMD Pharmaceuticals, Inc.?
The date of the name change from MyMD Pharmaceuticals, Inc. was 20210420.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding TNF Pharmaceuticals, Inc. (QCLS).